He Liang Fu
Presidente en JIANGSU AIDEA PHARMACEUTICAL CO., LTD. .
Fortuna: 3 M $ al 30/04/2024
Perfil
He Liang Fu is currently the Chairman at Jiangsu Aidea Pharmaceutical Co., Ltd.
He previously held the position of President at Techpool Bio-Pharma Co., Ltd.
and was a Professor at Sun Yat-Sen University.
He obtained his undergraduate degree from Nanjing University in 1989.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
29/12/2022 | 1 167 600 ( 0.23% ) | 2 M $ | 30/04/2024 | |
30/08/2022 | 721 283 ( 0.33% ) | 1 M $ | 30/04/2024 |
Cargos activos de He Liang Fu
Empresas | Cargo | Inicio |
---|---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Presidente | 01/01/2014 |
Antiguos cargos conocidos de He Liang Fu.
Empresas | Cargo | Fin |
---|---|---|
Sun Yat-Sen University | Corporate Officer/Principal | - |
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Presidente | - |
Formación de He Liang Fu.
Nanjing University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Techpool Bio-Pharma Co., Ltd.
Techpool Bio-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Techpool Bio-Pharma Co., Ltd. researches, develops, manufactures, and markets bio-pharmaceutical products. Its products include Techpool Roan, Kailikang, Bondronat and Roxin. The firm specializes in the sales, research and development, and production of biopharmaceuticals in critical care. The company was founded in 1993 and is headquartered in Guangzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- He Liang Fu